This week in European sciences -- week 35 |
Overview
|
>> former issues | ||
|
|||
With the
introduction of Viagra, it became acceptable to talk about "erectile
disfunction." As a matter of fact, Viagra has become such a success
that GlaxoSmith Kline and Bayer introduced Levitra as a treatment for
impotence. Levitra has received the "heads up" from the Food
and Drug Administration in the United States, according to a report in
Time (September
1-issue, 2003). "Both pills begin working within 30 minutes (although
some say Levitra works sooner), both last four to five hours, and both
are effective nearly 70 percent of the time," Dr. Sanjay Gupta writes
in the Time article. Side effects include headaches, nasal stuffiness
and an upset stomach. |
|
Time September 1 , 2003 |
|
Donald Kennedy,
editor-in-chief of Science
magazine, tells in his editorial contribution in FAZ (August 29, 2003)
the problems of European research from his American point of view: First,
research policy should act like sciences itself on a transnational level.
Up to now decisions in research policy are done by the national governments.
The shortcomings are obvious. Second, international cooperation is mandatory
to prevent the brain drain from Europe to the US. Kenndey goes that far
to ask US institutions to reduce search for human resources abroad. On
the other hand, more US scientists should gather experience outside the
US. And third, an important point in structuring the European research
area is the development of new priorities. Governmental science funding
has to value basic research more than applied research. |
|
Frankfurter
Allgemeine Zeitung August 29, 2003 |
|
In Reversal, U.S. Nears Deal On Drugs for Poor Countries The U.S.
government has changed its mind and intends to support an agreement that
would exempt poor nations from trade rules and allow them to buy generic
medicines. The change of heart could mean access to "expensive-patented"
medication for millions of people who suffer from diseases such as AIDS,
malaria and tuberculosis, Elizabeth Becker reports in the New York Times
(August
28, 2003, front page). The United States had rejected an agreement
to allow the trade rule exemptions last December. "After weeks of
intensive negotiations, the United States won assurances that countries
would not take advantage of the arrangement to increase exports of generic
drugs to nationas that are not poor and do not have a medical emergency,"
Becker writes. Peter Allgeier, United States deputy trade representative,
is working on negotiations in Geneva, Switzerland, and hopes an agreement
can be reached before the World Trade Organization meeting in Cancun,
Mexico, which begins Sept. 10. |
|
New
York Times August 28, 2003 |
|
Heart-Transplant Complications Cut By New Drug A study of
634 heart-transplant recipients indicates that everolimus, a drug developed
by Swiss pharmaceutical company Novartis helps reduce complications in
heart-transplant surgeries and helps prevent rejection of the donor-heart.
The Food and Drug Administration has not approved the use of everolimus
yet. Currently U.S. surgeons use the generic drug azathioprine to prevent
rejection and long-term thickening of the heart's coronary arteries. According
to the study published this week in the New England Journal of Medicine,
everolimus is more effective than azathioprine. However, not all of the
findings were favorable to everolimus, Daniel Golden reports in The Wall
Street Journal (August 28,
2003, front page). Both drugs registered the same death rates after
450 days after surgery. |
|
The
Wall Street Journal August 28, 2003 |
|
Decades of
acid rain have endangered and destroyed much of the wildlife in rivers
and lakes in Wales. Some 120,000 kilometers of streams and rivers in the
Welsh hills are polluted by acid rain, reports Malcolm Smith in The Guardian
(August
28, 2003). Indeed, air got much more cleaner the last decades, but
as Smith points out full recovery of acidified rivers will take, at best,
many years. Expert groups now try to speed recovery up: By dosing lime
into polluted water or on the soil beside. |
|
The
Guardian August 28, 2003 |
|
Ralf
Grötker
explains
elusive tricks to manipulate decision making by humans or animals. Especially
the so-called decoys get attention: irrelevant alternatives for instance
as appraised products in a shop alter the outcome of a buy decision completely. |
|
Die
Zeit August 28, 2003 |
|
Popular Antidepressant Effective in Children, Researchers Say Researchers
find the antidepressant Zoloft to be "an effective and well-tolerated
short-term treatment" for moderate to severe depression in children
and adolescents. "The research, the largest published study of children
to test any of the antidepressants known as selective serotonin reuptake
inhibitors, or S.S.R.I.'s, found that 69 percent of the subjects who took
the drug improved significantly, compared with 59 percent of those who
took a dummy pill, a difference that some experts termed modest,"
Erica Goode reports in The New York Times (August
27, 2003, front page). Fifty-three medical centers in the United States,
Canada, India, Costa Rica, and Mexico participated in the 18-month study,
whose results were published in The Journal of the American Medical Association.
Dr. Graham Emslie, a professor of psychiatry at the University of Texas
Southwestern Medical Center, who did not participate in this study but
has extensively researched effects of Paxil and Prozac, said the number
of children who improved while taking "dummy pills" indicates
the significance of environmental effects on children. |
|
New
York Times August 27, 2003 |
|
Radiodiagnosis
saves lifes. X-ray techniques developed rapidly followed by more and more
treatments. But radiation may also be harmfull if the amout of treatments
and dosages are too high, as Reinhard Wandtner points out in FAZ (August
27, 2003). Hence, the lesser the dosage the lesser the risk to damage
cells. To image bones, organs or teeth about 1665 X-ray examinations per
1000 people are done in Germany. In UK only 704. Only Japan tests more
(2316). What strucks more is the comparison on used dosages: The average
per person in Germany is two Millisievert, in France and Switzerland about
half that much and in UK only one sixth. As we think that radiodiagnosis
in Germany is not six times as powerful as in UK, the treatments should
be compared in more detail. |
|
Frankfurter
Allgemeine Zeitung August 27, 2003 |
|
Andrew
Pollack reports
on a new US military research strategy to use biotechnology for nonmedical
purposes. The Institute for Collaborative Biotechnologies is located at
the University of California at Santa Barbara, with some of the work also
to be done at the California Institute of Technology and the Massachusetts
Institute of Technology. The initial grant is for up to $50 million over
five years. Research subject are sensors, computers and materials. |
|
New
York Times August 26, 2003 |
|
Manfred
Dworschak
writes
on some curiosity: actually there are three different times used. The one
measured by physicists with atomic clocks, the one given by the GPS satellite
system and the one used by astronomers. The astronomer's time follows the
atomic reading by 32 seconds. The differences explain by the slowing down
of earth rotation. To bring the rotation in synchronization with celestial
events astronomers use leap-seconds. So does society. Now computer scientists
are afraid of some data hiccup by the leap-seconds. Because many applications
depent on accurate timing scientists are warning against turmoil in stock
exchange computers and autopilots. |
|
Der
Spiegel August 25, 2003 |
|
Computer viruses enter every week the media's headlines. Researchers try now to take the analogy of these bugs to biological entities on step further, as Manuela Lenzen and Martin Klaus report in FAZ on Sunday (August 24, 2003). Firewalls and anti-virus programs may act comparable to the skin of humans. Researches now seek for something acting like an immune system. They try to adopt the concept of antigenes to computers to distinguish between its own processes and programs and strange ones. |
|
FAZ
on Sunday August 24, 2003 |
|
Boris
Holzer looks
one more time on the "small world". He gaves some critics
on the experiment - inspiring, but partly useless. |
|
||
Blackout due to inadequate communications James Glanz
and Andrew Revkin explain how the blackout of most of northeast US happened:
"the system for communication among the people and organizations
that operate that part of the nation's electrical grid was inadequate."
NY Times, August
23, 2003 |
|
New
York Times August 23, 2003 |
Feedback |
We are glad to receive your comments! Send us an e-mail |